Frequently Asked Questions
Yes. The CDC, FDA and Washington State Department of Health have all recommended resuming use of the Johnson & Johnson vaccine immediately and we are following that guidance.
Our limited supply of the Johnson & Johnson vaccine is currently being administered primarily through in-patient programs. We are using the Pfizer and Moderna vaccines primarily at our five vaccination sites.
We continue to follow the latest guidance from the CDC, FDA and Washington State Department of Health with regard to COVID-19 vaccine safety and administration. All of those agencies have recommended resuming use of the Johnson & Johnson vaccine immediately.
We paused our administration of the Johnson & Johnson vaccine for nearly two weeks, starting April 13 following recommendations from the CDC, FDA and Washington State Department of Health.
As of April 26, we have administered less than 1,500 doses of the Johnson & Johnson vaccine, representing less than one percent of patients who have received at least one dose of the vaccine through UW Medicine.
Although the known risks of an adverse event from the Johnson & Johnson vaccine are exceedingly rare, we understand getting the vaccine is a personal choice. We cannot guarantee which vaccine will be available at the time of your appointment at UW Medicine, but encourage you to speak with your health care provider if you have questions or concerns.
People who received the Johnson & Johnson vaccine over three weeks ago are at very low risk for this complication.
Those who have received the Johnson & Johnson vaccine within the last three weeks should contact their health care provider or seek medical care if they develop severe headache, abdominal pain, leg pain or shortness of breath.